Key Points
- Insider sale: Plexus insider Michael Running sold 510 shares on Friday, June 5, at an average price of $272.17, generating about $138,807. After the sale, he retained 665 shares, a 43.4% reduction in his position.
- Recent performance: Plexus stock was up 3.4% and opened at $282.29, near its 52-week high of $292.33. The company now has a market cap of $7.55 billion.
- Fundamentals and outlook: Plexus beat quarterly earnings expectations, reporting $2.05 EPS versus $1.87 expected on revenue of $1.16 billion, up 18.7% year over year. Analysts remain mostly positive, with a consensus rating of Moderate Buy and several firms raising price targets.
Plexus Corp. (NASDAQ:PLXS - Get Free Report) insider Michael Running sold 510 shares of the business's stock in a transaction on Friday, June 5th. The stock was sold at an average price of $272.17, for a total transaction of $138,806.70. Following the transaction, the insider directly owned 665 shares of the company's stock, valued at approximately $180,993.05. This represents a 43.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Plexus Stock Up 3.4%
PLXS stock opened at $282.29 on Tuesday. The stock has a market capitalization of $7.55 billion, a price-to-earnings ratio of 41.27 and a beta of 0.89. The company has a 50-day moving average of $246.76 and a two-hundred day moving average of $200.76. Plexus Corp. has a 52-week low of $115.35 and a 52-week high of $292.33. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.54 and a quick ratio of 0.74.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its quarterly earnings data on Wednesday, April 29th. The technology company reported $2.05 EPS for the quarter, topping analysts' consensus estimates of $1.87 by $0.18. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same period in the previous year, the company posted $1.66 earnings per share. The firm's revenue for the quarter was up 18.7% on a year-over-year basis. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, equities research analysts anticipate that Plexus Corp. will post 5.98 EPS for the current year.
Hedge Funds Weigh In On Plexus
Large investors have recently added to or reduced their stakes in the company. Covestor Ltd lifted its position in shares of Plexus by 207.7% in the 4th quarter. Covestor Ltd now owns 240 shares of the technology company's stock worth $35,000 after acquiring an additional 162 shares during the period. Allworth Financial LP increased its position in shares of Plexus by 70.1% during the third quarter. Allworth Financial LP now owns 250 shares of the technology company's stock valued at $36,000 after purchasing an additional 103 shares during the period. Johnson Financial Group Inc. acquired a new position in shares of Plexus in the third quarter valued at $72,000. Farther Finance Advisors LLC raised its stake in shares of Plexus by 114.7% in the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company's stock valued at $75,000 after purchasing an additional 273 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in Plexus by 583.3% in the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company's stock worth $78,000 after purchasing an additional 490 shares during the period. Institutional investors and hedge funds own 94.45% of the company's stock.
Wall Street Analysts Forecast Growth
PLXS has been the subject of a number of research analyst reports. Zacks Research lowered Plexus from a "hold" rating to a "strong sell" rating in a report on Wednesday, May 20th. Benchmark restated a "buy" rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Wall Street Zen upgraded shares of Plexus from a "hold" rating to a "buy" rating in a research note on Saturday, May 2nd. Raymond James Financial reissued an "outperform" rating and issued a $275.00 price target on shares of Plexus in a report on Thursday, April 30th. Finally, Needham & Company LLC raised their price target on shares of Plexus from $285.00 to $310.00 and gave the stock a "buy" rating in a research report on Monday, June 1st. Five research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Plexus has a consensus rating of "Moderate Buy" and a consensus price target of $238.33.
Check Out Our Latest Analysis on Plexus
Plexus Company Profile
(
Get Free Report)
Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].